In vivoin vitro correlation for amoxicillin trihydrate 1000 mg dispersible tablet IVIVC for amoxicillin trihydrate 1000 mg dispersible tablet

Drug Development and Industrial Pharmacy

Volumn 35, Issue 8, 2009, Pages 981-985

  Ostrowski, Michał ^a   Wilkowska, Ewa ^a   Baczek, Tomasz ^b,c  

^a Polfa Warszawa SA   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

; IVIVC; Amoxicillin; Dispersible tablets; Dissolution; In vivo?in vitro correlation; Model of absorption

Indexed keywords

AMOTAKS; AMOXICILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED RELEASE FORMULATION; DISPERSIBLE TABLET; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG SOLUBILITY; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; HYDRODYNAMICS; MALE; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NORMAL HUMAN; BIOAVAILABILITY; BIOLOGICAL MODEL; CLINICAL TRIAL; SOLUBILITY; TABLET;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; SOLUBILITY; TABLETS; YOUNG ADULT;

EID: 70350688077     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902737492     Document Type: Article

References (6)

1. Westphal JF. (1991). Reappraisal of amoxicillin absorption kinetics. J Antimicrob Chemother, 27:647-654
2. Cortvriendt WRE. (1987). Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration. Arzneimittelforschung/ Drug Res, 37:977-981
3. Barr WH. (1994). Differential absorption of amoxicillin from the human small and large intestine. Clin Pharmacol Ther, 56:279-285
4. Wagner JG, Nelson E. (1963). Percent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci, 52:610-611
5. U.S. Food and Drug Administration (FDA). (1997). Guidance for Industry. Extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations, U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food and Drug Adminstration, Rockville, MD.
6. Erah PO. (1997). The stability of amoxicillin, clarithromycin and metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. J Antimicrob Chemother, 39:5-12.